Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Tango Therapeutics, Inc. (TNGX), most recent 12 months reported: revenue $53.81M, net loss $123.72M, free cash flow -$139.93M. Latest balance sheet on file: liquid cash $1.01B. From SEC filings. More on Tango Therapeutics, Inc.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: AYTU BIOPHARMA, INC. · Nektar Therapeutics · PROTHENA CORPORATION PUBLIC LIMITED COMPANY · Aquestive Therapeutics, Inc. · Q32 Bio Inc. · Siga Technologies INC · GOSSAMER BIO, INC. · OCULAR THERAPEUTIX, INC
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.